Evidence map›Paper›PMID 29159066›Full record

ArticleEpilepsy & behavior case reports2017

Six adult patients with septo-optic dysplasia and drug-resistant epilepsy: Clinical findings and course.

Mashael AlKhateeb, Richard McLachlan, Jorge Burneo, David Diosy, Seyed Mirsattari

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epilepsy & behavior case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Septo-optic dysplasia plus: A case report for reviewing and recognizing this conditionBiomedica : revista del Instituto Nacional de Salud · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. [Septo optic dysplasia plus: about a case].The Pan African medical journal · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Mashael AlKhateebDepartment of Neuroscience, London health science center, Western University, London, Ontario, Canada.
Richard McLachlanDepartment of Neuroscience, London health science center, Western University, London, Ontario, Canada.
Jorge BurneoDepartment of Neuroscience, London health science center, Western University, London, Ontario, Canada.
David DiosyDepartment of Neuroscience, London health science center, Western University, London, Ontario, Canada.
Seyed MirsattariDepartment of Neuroscience, London health science center, Western University, London, Ontario, Canada.
London Health Sciences Centre · CAWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Septo-optic dysplasia (SOD) is a rare disorder associated with optic nerve hypoplasia, pituitary abnormalities and agenesis/dysgenesis of midline brain structures including the septum pellucidum and corpus callosum. Though sometimes associated with drug-resistant epilepsy, this association has not been well studied. We report six SOD patients with associated malformation of cortical development (MCD) and drug-resistant epilepsy who underwent video-EEG telemetry at our centre between 1998 and 2016 for drug-resistant epilepsy. ‬Three then underwent surgery; right temporal neocortical resection, right functional hemispherectomy and placement of a vagus nerve stimulator. Clinical findings and the patients' ultimate courses are discussed.

Indexed as

Cortical malformationDrug-resistantEpilepsySeizuresSeizure surgerySepto-optic dysplasia

Identifiers

PMID29159066
PMCPMC5678750
OpenAlexW2606162541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.